By Rodrigo Campos
NEW YORK (Reuters) - U.S. stocks rose on Tuesday, led by gains in the energy sector, and as Biogen rallied on news about an experimental treatment for Alzheimer's disease.
The day's gains were broad, with nine of the 10 S&P 500 industry sectors higher. The only group to fall was telecoms <.SPLRCL>, down 1.6 percent with AT&T
Energy shares on the S&P 500 <.SPNY> rose 1.6 percent even as crude oil prices resumed their fall. U.S. crude
Exxon Mobil
At 2:42 p.m. (1942 GMT) the Dow Jones industrial average <.DJI> rose 94.27 points, or 0.53 percent, to 17,871.07, the S&P 500 <.SPX> gained 12.43 points, or 0.61 percent, to 2,065.87 and the Nasdaq Composite <.IXIC> added 26.75 points, or 0.57 percent, to 4,754.09.
Carmaker shares advanced as the top six automakers sold more cars and trucks in November than analysts expected. GM
Biogen Idec Inc
Avanir Pharmaceuticals
Cypress Semiconductor Corp
Advancing issues outnumbered declining ones on the NYSE by 2,023 to 1,034, for a 1.96-to-1 ratio; on the Nasdaq, 1,820 issues rose and 866 fell for a 2.10-to-1 ratio.
The S&P 500 was posting 79 new 52-week highs and 5 new lows; the Nasdaq Composite was recording 97 new highs and 81 new lows.
(Reporting by Rodrigo Campos; Editing by Nick Zieminski)
Relacionados
- COMUNICADO: MUMM lanza el primer video musical de doble pantalla del mundo con David Guetta
- COMUNICADO: BMC: Primer éxito en la actual lucha por patente con ResMed (RMD) en EE. UU. y Alemania
- COMUNICADO: ArtBanc International anuncia el lanzamiento de la plataforma comercial de ArtBanc
- COMUNICADO: Los líderes religiosos del mundo firmaron una declaración para erradicar la esclavitud moderna (y 2)
- COMUNICADO: Los líderes religiosos del mundo firmaron una declaración para erradicar la esclavitud moderna (1)